This is the authors' abstract. We don't add key points for this paper.
BACKGROUND: malignancies in liver transplant patients. AIM: malignancies in liver transplant recipients. METHODS: malignancies were reported. Likewise, the review assesses the differences in adult and pediatric recipients by describing the adopted immunosuppression regimens and the different type of diagnosed solid and blood malignancy. RESULTS: malignancies is difficult to ascertain because data have not been specified in most of the clinical experiences. CONCLUSION: malignancies and may also help in treating liver transplant patients suffering from cancer.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Manzia et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: